CV vs TECH
CapsoVision, Inc. Common Stock (CV) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
CapsoVision, Inc. Common Stock (CV) is a medical devices company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CV revenue for 2025-09-30 was $3.5M. Net income was -$7.9M. Revenue was up 6.7% from 2025-06-30 to 2025-09-30. CV currently screens at market cap $359.2M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CV currently screens at market cap $359.2M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CV and TECH stock pages for the full models.
Not investment advice.